.svg){kind=small}
Oct-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Is this your brand?
See your full sales and distribution data: where you sell, how you're priced, and how you rank against the brands next to you on the shelf.
See your brand's dataCarry this brand in your store?
Headset Retailer is free. Connect your POS and see what's selling and what's sitting.
Sign up freeWhere to Buy
CannaBiotix (CBX) is stocked at 464 licensed dispensaries across California, with the deepest coverage in Los Angeles, San Diego, Santa Ana, Sacramento, and La Mesa. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
In October 2026, CannaBiotix (CBX) concentrated 60.44% of sales in Flower, where sales fell 16.66% year over year but rose 8.72% month over month, while Pre-Roll held 26.09% share with sales up 7.79% YoY and 9.31% MoM. Concentrates accounted for 10.45% share with a 25.90% YoY increase but a 1.00% MoM dip, and Vapor Pens, at 2.97% share, surged 166.71% YoY with flat 0.03% MoM movement. Despite a 5.78% YoY brand sales decline and a 9.90% YoY drop in average price to $24.06, Pre-Roll and Concentrates gains partially offset Flower’s YoY contraction. The mix shift indicates reliance on Flower remains high while momentum has pivoted toward Pre-Roll and Concentrates, implying that incremental growth is coming from non-Flower formats even as the core category still drives absolute volume.
Holding rank 3 in Flower in California while Flower share sits at 60.44% and YoY sales in that category are down 16.66% creates exposure that recent 8.72% MoM Flower growth cannot fully hedge. The 7.79% YoY and 9.31% MoM expansion in Pre-Roll alongside a 25.90% YoY lift in Concentrates and a 166.71% YoY rise in Vapor Pens, combined with a 9.90% YoY average price decline, point to a volume-led posture that trades some price for share in faster-moving formats. The pattern implies CannaBiotix (CBX) is repositioning from a premium-weighted Flower anchor toward a broader value-accessible portfolio, using Pre-Roll and Concentrates to stabilize growth while maintaining Flower visibility at a top-3 rank.
Competitive Landscape
CannaBiotix (CBX) sits at rank #3 in CA Flower in October 2026 after a year-over-year drop from #1, while holding at #3 since July–September and coming off a peak at #1 in January 2026; in contrast, STIIIZY is currently #1 after rising from #2 year over year with a 44.5% YoY sales gain, and CAM climbed from #3 to #2 with 60.0% YoY growth, putting pressure on CBX’s position. With Oakfruitland jumping from #11 to #4 on 109.1% YoY growth and Allswell holding #5 after improving from #4, the competitive set is closing the gap, implying CBX’s slide from #1 to #3 and flat three-month rank signals share consolidation risk unless the brand reaccelerates velocity or assortment depth.
Notable Products
CannaBiotix (CBX) priced well above peers in October 2026, with brand-wide averages 47.3% higher than similar products and Cereal Milk (14g) at a 214.5% premium to comparable flower. With this pricing profile and 34.7% of sales in Hybrid flower, much of its revenue comes from higher-priced flower, so most of its sales ride on premium-priced formats.
Peer avg: average price of the same product type and package size in the same states that month.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
